Walgreens Boots Alliance (NASDAQ:WBA) Posts Quarterly Earnings Results, Beats Estimates By $0.13 EPS

Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Friday. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13, RTT News reports. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the company posted $0.66 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Trading Up 27.5 %

Shares of WBA stock opened at $11.76 on Friday. The stock has a 50-day moving average of $9.26 and a 200-day moving average of $9.89. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $24.93. The stock has a market cap of $10.15 billion, a price-to-earnings ratio of -1.17, a PEG ratio of 1.36 and a beta of 0.64. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 8.50%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

Several analysts recently weighed in on WBA shares. TD Cowen dropped their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Jefferies Financial Group dropped their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. UBS Group lifted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Finally, Morgan Stanley dropped their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.